Safety and Efficacy of Licaminlimab Ophthalmic Suspension for the Treatment of Signs and Symptoms of Dry Eye Disease (clinicaltrials.gov) - Jun 9, 2023 - P2 | N=120 | Not yet recruiting | Sponsor: Oculis
New P2 trial • Dry Eye Disease • Ophthalmology
|